The Impact Of SGLT2 -I on Metabolic Dysfunction -Associated Steatotic Liver Disease In Patients With Type 2 Diabetes Mellitus
Conditions: Fatty Liver, Nonalcoholic Interventions: Drug: SGLT2 inhibitor Sponsors: Sohag University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Fatty Liver Disease (FLD) | Liver | Liver Disease | Research | SGLT2 Inhibitors | Urology & Nephrology